Docket #: S20-224
Algorithm for Maximizing mRNA Thermodynamic Stability
Stanford researchers have developed a stochastic algorithm MC sampler for designing mRNAs showing improved translation in vitro. It is known that degradation of RNA molecules at ambient conditions presents a major challenge for wide scale distribution of RNA-based vaccines. Recent studies have suggested that the translational efficiency of mRNA molecules is related to the degree of structure present in the molecule, but little is known about the optimal method to increase structure. The researchers developed a stochastic algorithm that samples nucleotides within synonymous codons to minimize the thermodynamic free energy of an mRNA molecule. A key innovation is that it selects nucleotides to mutate in proportion to their probability of being unpaired. This has been demonstrated to accelerate minimization by focusing sampling on regions lacking structure.
This technology is part of a portfolio of innovations aimed at fighting the COVID-19 pandemic.
Stage of Development
In vitro demonstration
Explore more RNA vaccine technologies and tools:
Stanford docket S20-183 - mRNA Vaccines: Methods of Synthesis and Stability Assessment
Stanford docket S20-258 - Additive Reduces Cost of Manufacturing mRNA
Applications
- mRNA design
- mRNA synthesis
- mRNA vaccine design
- COVID-19 mRNA vaccine design
Advantages
- Supports improved translation and stability of prospective mRNA vaccines
Publications
- Leppek et al. bioRxiv (2021) Combinatorial optimization of mRNA structure, stability, and translation for RNA-based therapeutics
Related Links
Similar Technologies
-
Eterna Enterprise: A Secure Platform for Designing Enhanced mRNA Vaccines S20-217Eterna Enterprise: A Secure Platform for Designing Enhanced mRNA Vaccines
-
EternaFold2: A general method for end-to-end nucleic acid structure inference S21-250EternaFold2: A general method for end-to-end nucleic acid structure inference
-
Optimized Synthesis and Translation of RNA Therapeutics S20-174Optimized Synthesis and Translation of RNA Therapeutics